Akums Drugs Pharmaceuticals Announcements
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
04 Apr, 2026 | 01:04pm • Source: BSE
Bharat Connect Conference
26 Feb, 2026 | 12:47pm • Source: BSE
Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Transcript
19 Feb, 2026 | 10:59am • Source: NSE
Earnings Call Transcript
19 Feb, 2026 | 10:30am • Source: BSE
Audio Recording Q3 FY2025-26
16 Feb, 2026 | 03:02pm • Source: BSE
Approval of Un-audited Financial Results for the quarter and nine months ended 31.12.2025.
13 Feb, 2026 | 04:13pm • Source: BSE
Outcome of Board Meeting held on 13th February, 2026
13 Feb, 2026 | 04:08pm • Source: BSE
Schedule of the Earnings / Analysts Conference Call (group meet) for Un-audited financial results of Q3 FY26.
31 Jan, 2026 | 03:22pm • Source: BSE
Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to...
31 Jan, 2026 | 03:11pm • Source: BSE
Certificate under Reg 74(5) of SEBI(DP) Regulations, 2018
07 Jan, 2026 | 04:47pm • Source: BSE
Resignation of Senior Management Personnel
27 Dec, 2025 | 04:36pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ruby Qc Investment Holdings Pte...
22 Dec, 2025 | 03:40pm • Source: BSE
Plant Visit of Investors / Financial Institutions on 12.12.2025
09 Dec, 2025 | 03:08pm • Source: BSE
JM Financial India Conference 2025
17 Nov, 2025 | 01:23pm • Source: BSE
Earning call transcript
17 Nov, 2025 | 01:19pm • Source: BSE